• New Cd136 (RON)-PE Ruo Monoclonal Antibody Identifies Potential Marker of Epithelial Cells

Laboratory Products

New Cd136 (RON)-PE Ruo Monoclonal Antibody Identifies Potential Marker of Epithelial Cells

Mar 13 2006

Beckman Coulter introduces IOTest® CD136 (RON)-PE conjugated monoclonal antibody for the identification of a receptor protein kinase potentially involved in tumour development and growth. The CD136 antigen is the product of the recepteur d'origine nantais (RON) gene. It is mainly expressed on cells of epithelial origin. The RON receptor belongs to a group of kinases that play important regulatory roles in normal tissue and can also be involved in cellular disorganization and alteration when overexpressed or mutated.

The new CD136 (RON) antibody from Beckman Coulter will be valuable in a range of basic and clinical research, and has been used in a number of recent and current cancer studies. It will also be useful in pharmaceutical research on therapies designed to block the tumorigenic process. The preformulated, standardized IOTest CD136 (RON)-PE monoclonal antibody is provided in 100-test vials and is the only directly conjugated monoclonal antibody on the market. It can be used to assess RON expression on both normal and abnormal epithelial cells, recognizing proRON and RON, and the three known RON variants. CD136 (RON)-PE is approved for research use only.

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events